Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 5Recurrence 3Hepatitis B 3Lymphoma 2Virus Diseases 1Neoplasms 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Glioma 1Extensive Stage Lung Small Cell Carcinoma 1Colorectal Neoplasms 1

Interventions

atezolizumab 3Etoposide 2Carboplatin 2lipoarabinomannan 1bomedemstat 1Lamivudine 1LB100 1Immunoglobulin G 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Extensive Stage Lung Small Cell Carcinoma × Lamivudine × Clear all
NCT04696575 2025-12-15

Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer

Roswell Park Cancer Institute

Phase 2 Recruiting
28 enrolled

Extensive Stage Lung Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡